Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

Volume: 47, Issue: 3, Pages: 552 - 573
Published: Nov 20, 2021
Abstract
Neurodegenerative disorders are distinguished by the gradual deterioration of the nervous system’s structure and function due to oxidative stress, mitochondrial dysfunction, protein misfolding, excitotoxicity, and neuroinflammation. Among these NDs, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis characterized an increasing dysfunction and loss of neuronal structure leading to neuronal cell...
Paper Details
Title
Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Published Date
Nov 20, 2021
Volume
47
Issue
3
Pages
552 - 573
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.